LY-366634

N/A

Report date: 2022/08/24 20:00:31
NME

Base Information

Drug NameLY-366634
Drug Alias NameBDF-9196
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channels stimulants
TargetsSodium channels
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A